Purple Biotech Ltd (TLV:PPBT)
1.100
0.00 (0.00%)
Oct 5, 2025, 3:16 PM IDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of 19.88 million as of October 7, 2025. Its market cap has decreased by -62.31% in one year.
Market Cap
19.88M
Enterprise Value
432.26K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.10
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 19.88M, an increase of 11.22%. That is a compound annual growth rate of 0.87%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 5, 2025 | 19.88M | -50.71% |
Dec 31, 2024 | 40.34M | -48.30% |
Dec 31, 2023 | 78.02M | -17.30% |
Dec 29, 2022 | 94.35M | -55.64% |
Dec 30, 2021 | 212.71M | -1.36% |
Dec 31, 2020 | 215.65M | 332.51% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 74.99B |
Danel (Adir Yeoshua) | 3.10B |
Kamada | 1.31B |
Bait Bakfar | 1.01B |
BrainsWay | 977.55M |
SofWave Medical | 960.10M |
Ilex Medical | 714.47M |
Novolog (Pharm-Up 1966) | 649.83M |